EDGAR Filing Documents for 0001104659-23-068973

Form 8-K/A - Current report: [Amend]

SEC Accession No. 0001104659-23-068973

Filing Date

2023-06-07

Accepted

2023-06-07 17:18:57

Documents

Period of Report

2023-06-06

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K/A	tm2317653d6_8ka.htm iXBRL	8-K/A	41135
2	EXHIBIT 4.1	tm2317653d6_ex4-1.htm	EX-4.1	106766
3	EXHIBIT 4.2	tm2317653d6_ex4-2.htm	EX-4.2	11110
4	EXHIBIT 5.1	tm2317653d6_ex5-1.htm	EX-5.1	12959
5	EXHIBIT 10.1	tm2317653d6_ex10-1.htm	EX-10.1	232336
6	EXHIBIT 10.2	tm2317653d6_ex10-2.htm	EX-10.2	25227
7	EXHIBIT 99.1	tm2317653d6_ex99-1.htm	EX-99.1	13695
12	GRAPHIC	tm2317653d6_ex5-1img001.jpg	GRAPHIC	4954
	Complete submission text file	0001104659-23-068973.txt		778383

Data Files

Seq	Description	Document	Type	Size
8	XBRL TAXONOMY EXTENSION SCHEMA	nrxp-20230606.xsd	EX-101.SCH	3314
9	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	nrxp-20230606_def.xml	EX-101.DEF	27169
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	nrxp-20230606_lab.xml	EX-101.LAB	36768
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	nrxp-20230606_pre.xml	EX-101.PRE	25791
14	EXTRACTED XBRL INSTANCE DOCUMENT	tm2317653d6_8ka_htm.xml	XML	5168

Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801

Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134

NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)